Find your next paid study

Leiden University Medical CenterNCT06932081

Actual pay is set by the research site.

Effects of Resistance Exercise Among TGD Individuals Initiating Estrogen-Based Gender-Affirming Hormone Therapy

Estrogen-dominant gender-affirming hormone therapy (GAHT) is standard of care for transgender women and gender-diverse individuals and typically consists of es…

Muscle Mass and Strength

Massachusetts General HospitalNCT07400419

Actual pay is set by the research site.

Lung CancerNSCLCBrain Metastases

DURABLE: Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and rEarrangements

This study will consist of a Phase 1b and Phase 2 portion. The Phase 1b portion will enroll first followed by the Phase 2 portion. Each cycle of treatment = 28…

Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Primary Peritoneal CarcinomaPARP Inhibitor+1 more

~$150 – $4,500

Actual pay is set by the research site.

Joshua PalmerNCT05987644

Phase 2

Phase II Clinical Trial Combining the Hedgehog Inhibitor Vismodegib With the PD-L1 Inhibitor Atezolizumab in Patients With Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

This trial will treat patients with platinum resistant ovarian, fallopian tube or primary peritoneal cancer as defined by a progression free interval within si…

Ronald BuckanovichNCT05538091

~$75 – $3,000

Actual pay is set by the research site.

RADIANT Study: Pre-op Radiation With Abemaciclib Andletrozole in Early Stage Breast Cancer

This phase 1b study investigates the safety and feasibility of combining pre-operative radiation therapy with Cyclin-Dependent Kinase 4 (CDK4/6) inhibitors in …

Breast Cancer

Mridula George, MDNCT06139107

~$150 – $4,500

Actual pay is set by the research site.

Phase 4

Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study.

Lichen planopilaris (LPP) is a primary lymphocytic cicatricial alopecia characterized by progressive, permanent hair loss and scalp symptoms such as pruritus a…

Lichen Plano-Pilaris

The Skin Center Dermatology GroupNCT07396168

~$25 – $1,500

Actual pay is set by the research site.

Phase 3

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

The goal of the study is to learn how a weight loss medication called semaglutide, which is used to treat obesity, in addition to standard AF treatment might a…

Overweight or ObesityAtrial Fibrillation

University of ChicagoNCT06499857

~$50 – $1,500

Actual pay is set by the research site.

Technical Success, Safety, and Short and Long-term Efficacy for MR-Guided Cryoablation of Prostate Bed Recurrences

The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.

Prostate Tumors

Actual pay is set by the research site.

Mayo ClinicNCT01727284

Caregivers of Hematopoietic Stem Cell Transplant (HCT) Patients

Development of a Mindfulness-Based Smartphone Application for BMT Caregivers

This pilot study evaluates the feasibility, acceptability, usability, and engagement of a smartphone-delivered mindfulness intervention for caregivers of hemat…

H. Lee Moffitt Cancer Center and Research InstituteNCT07352943

Actual pay is set by the research site.

A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours

Multi-site, open-label, first-in-human study with 2 parts (dose escalation and dose expansion) in subjects with selected advanced solid tumours

Solid Tumours

Orion Corporation, Orion PharmaNCT06725758

~$150 – $4,200

Actual pay is set by the research site.

Advanced Malignant Solid NeoplasmLocally Advanced Pancreatic CarcinomaMetastatic Pancreatic Carcinoma+6 more

Phase Ib/II Study of ZEN003694 and Entinostat in Advanced and Refractory Solid Tumors

This phase I/II trial tests the safety, side effects, and best dose of entinostat and ZEN003694 in treating patients with solid tumors that have spread to othe…

National Cancer Institute (NCI)NCT05053971

~$150 – $2,700

Actual pay is set by the research site.

Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans

This study aims to explore the mechanisms of how transcranial magnetic stimulation (TMS) impacts fear circuits. The overarching objectives are to understand ho…

PTSD